- Home
- ALOT vs BYSI Comparison
ALOT vs BYSI Comparison
Compare ALOT & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- BYSI
- Stock Information
- Founded
- ALOT 1969
- BYSI 2010
- Country
- ALOT United States
- BYSI United States
- Employees
- ALOT N/A
- BYSI N/A
- Industry
- ALOT Computer peripheral equipment
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- ALOT Technology
- BYSI Health Care
- Exchange
- ALOT Nasdaq
- BYSI Nasdaq
- Market Cap
- ALOT 69.2M
- BYSI 71.0M
- IPO Year
- ALOT N/A
- BYSI 2017
- Fundamental
- Price
- ALOT $9.01
- BYSI $3.15
- Analyst Decision
- ALOT
- BYSI
- Analyst Count
- ALOT 0
- BYSI 0
- Target Price
- ALOT N/A
- BYSI N/A
- AVG Volume (30 Days)
- ALOT 19.0K
- BYSI 140.7K
- Earning Date
- ALOT 06-05-2025
- BYSI 08-11-2025
- Dividend Yield
- ALOT N/A
- BYSI N/A
- EPS Growth
- ALOT N/A
- BYSI N/A
- EPS
- ALOT N/A
- BYSI N/A
- Revenue
- ALOT $156,030,000.00
- BYSI N/A
- Revenue This Year
- ALOT N/A
- BYSI N/A
- Revenue Next Year
- ALOT N/A
- BYSI N/A
- P/E Ratio
- ALOT N/A
- BYSI N/A
- Revenue Growth
- ALOT 7.14
- BYSI N/A
- 52 Week Low
- ALOT $7.53
- BYSI $0.98
- 52 Week High
- ALOT $17.24
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- ALOT 48.12
- BYSI 72.10
- Support Level
- ALOT $8.91
- BYSI $2.73
- Resistance Level
- ALOT $9.39
- BYSI $3.44
- Average True Range (ATR)
- ALOT 0.40
- BYSI 0.33
- MACD
- ALOT -0.02
- BYSI 0.12
- Stochastic Oscillator
- ALOT 9.17
- BYSI 81.49
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.